A new study finds that under 30% of radiology-focused AI/ML devices authorized by the FDA had clinical testing prior to authorization.
Key Details
- 1FDA has cleared over 1,000 AI/ML devices, most for radiology.
- 2Research published in JAMA Network Open reviewed almost 1,000 algorithms approved from 1995 to June 2024.
- 3Of 723 radiology devices, fewer than 30% underwent any form of clinical testing.
- 4Very few devices were subject to prospective trials before clearance.
- 5Authors highlight a lack of standards for safety and efficacy in FDA authorization of AI/ML devices.
Why It Matters
The rapid proliferation of AI/ML devices in radiology without adequate clinical validation raises concerns about patient safety and efficacy. The findings emphasize an urgent need for more rigorous regulatory oversight and defined testing standards for imaging AI tools.
Source
Radiology Business
Related News
•Radiology Business
Patients Favor AI in Imaging Diagnostics, Hesitate on Triage Use
Survey finds most patients support AI in diagnostic imaging but are reluctant about its use in triage decisions.
•HealthExec
FDA Eases Path for AI in Clinical Decision Support and Healthcare Innovation
FDA publishes new guidance to promote innovation in general wellness and clinical decision support, impacting medical AI including radiology.
•AuntMinnie
Deep Learning AI Outperforms Radiologists in Detecting ENE on CT
A deep learning tool, DeepENE, exceeded radiologist performance in identifying lymph node extranodal extension in head and neck cancers using preoperative CT scans.